Diagnostik und Therapie kardiorenaler Syndrome – Pathophysiologische Überlegungen und klinische Entscheidungshilfen

Das kardiorenale Syndrom (CRS) steht seit einigen Jahren zunehmend im Fokus klinischer Diagnostik und Therapie, aber auch zahlreicher klinischer Studien. Lange bevor dieser Begriff wesentlich durch Ronco geprägt wurde, fielen im klinischen Alltag die wechselseitigen Einflüsse von einer Herzinsuffizienz und deren Therapie auf die Nierenfunktion sowie umgekehrt einer Niereninsuffizienz und deren Einflüsse auf das kardiovaskuläre System auf. Diese Arbeit soll die Aspekte des klinischen Alltags von Diagnostik und Therapie bei Patienten mit kardiorenalem Syndrom beleuchten.

The cardiorenal syndrome got in the focus of discussion in the last years. Long before the term of CRS was named by Ronco, clinical routine revealed the interaction of heat-failure and its therapy with kidney-function, as well as the influence of chronic kidney disease on the cardiovascular system. This article is meant to point out the aspects of clinical routine regarding diagnostics and therapy of patients with cardiorenal syndrome.

Key words

Cardiorenal syndrome - heart-failure - kidney-function - clinical diagnostics - therapy

• Literatur

• 1 Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol 2008; 52: 1527-1539
• 2 Haase M, Müller C, Damman K et al. Pathogenesis of cardiorenal syndrome Type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013; 182: 99-116
• 3 Kumar N, Dahri L, Brown W et al. Effect of elective coronary angiography on glomerular filtration rate in patients with advanced chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 1907-1913
• 4 Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined. A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969
• 5 Thomas L, von Eckardstein A. Kardiale Erkrankungen. Aus Thomas L. Labor und Diagnose, 8. Auflage. TH-Books-Verlags-Gesellschaft 2012;
• 6 Scolari F, Ravani P. Atheroembolic renal disease. Lancet 2010; 375: 1650-1660
• 7 Rodby RA. Preventing complications of radiographic contrast media: is there a role for dialysis?. Semin Dial 2007; 20: 19-23
• 8 Mullens W, Abrahams Z, Francis GS. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009; 53: 589-596
• 9 Nohria A, Hasselblad V, Stebbins A et al. Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 2008; 51: 1268-1274
• 10 Cruz DN, Schmidt-Ott KM, Vescovo G et al. Pathophysiology of cardiorenal syndrome Type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013; 182: 117-1136
• 11 Kishimoto T, Maekawa M, Abe Y, Yamamoto K. Intrarenal distribution of blood flow and renin release during renal venous pressure elevation. Kidney Int 1973; 4: 259-266
• 12 Schwenger V, Remppis AB. Renal replacement therapy for refractory heart failure. Internist 2012; 53: 823-832
• 13 Bagshaw SM, Hoste EA, Braam B et al. Cardiorenal syndrome Type 3: pathophysiologic and epidemiologic considerations. Contrib Nephrol 2013; 182: 137-157
• 14 Wiedemann HP, Wheeler AP, Bernard GR et al. Comparison of two fluid-management strategies in acute lung injury. Clinical Trials Network, National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS). N Engl J Med 2006; 354: 2564-2575
• 15 Neirynck N, Vanholder R, Schepers E et al. An update on uremic toxins. Int Urol Nephrol 2013; 45: 139-150
• 16 Holmes CL, Walley KR. Bad medicine: low-dose dopamine in the ICU. Chest 2003; 123: 1266-1275
• 17 Tumlin JA, Costanzo MR, Chawla LS et al. Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013; 182: 158-173
• 18 Wali RK, Wang GS, Gottlieb SS et al. Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol 2005; 45: 1051-1060
• 19 Mehta RL, Rabb H, Shaw AD et al. Cardiorenal syndrome type 5: clinical presentation, pathophysiology and management strategies from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013; 182: 174-194